Market revenue in 2023 | USD 57.8 million |
Market revenue in 2030 | USD 102.6 million |
Growth rate | 8.6% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.27% in 2023. Horizon Databook has segmented the Germany clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Germany is another key location for clinical trials in Europe. Advancements in technology & high-quality clinical resources are some of the primary factors expected to propel the market over the forecast period.
The local presence of many major CROs offering clinical trial recruitment services is likely to contribute to market growth. However, high overhead costs are a major challenge in this region, due to which companies are shifting the location of their clinical trials to developing economies.
The global share of Germany in clinical trial activity is consistently declining. According to Global Data, Germany’s clinical trials accounted for 4.9% of the global clinical trial activity in 2018, whereas in 2021, they accounted for 3.9%.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into Germany clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account